| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21677-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB120-10394-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77046-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43338-0.5mg | |||
| BSA Free | NBP1-43338-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61697-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61693-0.025ml | |||
![Immunohistochemistry-Paraffin: B7-H3/CD276 Antibody [NBP2-32251] - Sample: FFPE section of human prostate carcinoma. Antibody: Affinity purified rabbit anti-B7-H3/CD276 (NBP2-32251). Detection: DAB Counterstain: IHC hematoxylin](http://images.novusbio.com/fullsize/B7-H3-CD276-Antibody-Immunohistochemistry-NBP2-32251-img0002.jpg "Immunohistochemistry-Paraffin: B7-H3/CD276 Antibody [NBP2-32251] - Sample: FFPE section of human prostate carcinoma. Antibody: Affinity purified rabbit anti-B7-H3/CD276 (NBP2-32251). Detection: DAB Counterstain: IHC hematoxylin")
![Immunohistochemistry-Paraffin: B7-H3/CD276 Antibody [NBP2-32251] - Samples: FFPE sections of MCF-7 cells (endogenous expression) and CD276 transfected Hek293 cells (over-expression). Antibody: Affinity purified rabbit anti-B7-H3/CD276 (NBP2-32251). Detection: DAB](http://images.novusbio.com/fullsize/B7-H3-CD276-Antibody-Immunocytochemistry-NBP2-32251-img0003.jpg)
![Immunoprecipitation: B7-H3/CD276 Antibody [NBP2-32251] - Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) prepared using NETN buffer from HeLa cells. Antibodies: Affinity purified rabbit anti-CD276 antibody NBP2-32251 used for IP at 6 ug per reaction. CD276 was also immunoprecipitated by rabbit anti-CD276 antibody BL16383. For blotting immunoprecipitated CD276 was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.](http://images.novusbio.com/fullsize/B7-H3-CD276-Antibody-Immunoprecipitation-NBP2-32251-img0001.jpg)
![Western Blot: CCR3 Antibody (SR2050) [NBP3-21677] - Western blot analysis using NBP3-21677 in K562 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21677_rabbit-ccr3-mab-sr2050-57202315545126.jpg "Western Blot: CCR3 Antibody (SR2050) [NBP3-21677] - Western blot analysis using NBP3-21677 in K562 cell lysate.")
![Immunohistochemistry: CCR3 Antibody (SR2050) [NBP3-21677] - Immunohistochemical analysis of paraffin-embedded human epidemal cells of skin, using NBP3-21677.](http://images.novusbio.com/fullsize/nbp3-21677_rabbit-ccr3-mab-sr2050-5720231716189.jpg)
![Western Blot: CXCR3 Antibody (3B7Y7) [NBP3-15369] - Western blot analysis of extracts of K-562 cells, using CXCR3 Rabbit mAb (NBP3-15369) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 3s.](http://images.novusbio.com/fullsize/CXCR3-Antibody-3B7Y7-Western-Blot-NBP3-15369-img0002.jpg "Western Blot: CXCR3 Antibody (3B7Y7) [NBP3-15369] - Western blot analysis of extracts of K-562 cells, using CXCR3 Rabbit mAb (NBP3-15369) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 3s.")
![Immunohistochemistry: CXCR3 Antibody (3B7Y7) [NBP3-15369] - Immunofluorescence analysis of mouse spleen using CXCR3 Rabbit mAb (NBP3-15369) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/CXCR3-Antibody-3B7Y7-Immunohistochemistry-NBP3-15369-img0001.jpg)
![Western Blot: ULBP1 Antibody [NBP2-20808] - Sample (30 ug of whole cell lysate) A: K562 12% SDS PAGE gel, diluted at 1:2000.](http://images.novusbio.com/fullsize/ULBP1-Antibody-Western-Blot-NBP2-20808-img0001.jpg "Western Blot: ULBP1 Antibody [NBP2-20808] - Sample (30 ug of whole cell lysate) A: K562 12% SDS PAGE gel, diluted at 1:2000.")
![Immunohistochemistry-Paraffin-ULBP1 Antibody [NBP2-20808] - Human cervical carcinoma.ULBP1 stained by ULBP1 antibody [N1C3] diluted at 1:500.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/antibody/nbp2-20808_rabbit-polyclonal-ulbp-1-antibody-immunohistochemistry-paraffin-72202412438..jpg)
![Immunohistochemistry-Paraffin: TLR5 Antibody (8-1#) [NBP3-41489] - DAB staining on IHC-P; Sample: Rat Lymph node Tissue; Primary Ab: 20ug/ml NBP3-41489; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-612202420503623.jpg "Immunohistochemistry-Paraffin: TLR5 Antibody (8-1#) [NBP3-41489] - DAB staining on IHC-P; Sample: Rat Lymph node Tissue; Primary Ab: 20ug/ml NBP3-41489; Second Ab: 2ug/mLÂ HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Western Blot: TLR5 Antibody (8-1#) [NBP3-41489] - Sample: Recombinant TLR5, Human.](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-612202421243247.jpg)
![Western Blot: TLR5 Antibody (8-1#) [NBP3-41489] - Sample: Rat Spleen lysate Primary Ab: 0.6ug/ml NBP3-41489; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-61220242142312.jpg)
![Western Blot: CCL11/Eotaxin Antibody [NBP1-77046] - HeLa cell lysate containing 10, 2.5, or 1 ng of full length recombinant eotaxin with eotaxin antibody at 1 ug/ml.](http://images.novusbio.com/fullsize/CCL11-Eotaxin-Antibody-Western-Blot-NBP1-77046-img0001.jpg "Western Blot: CCL11/Eotaxin Antibody [NBP1-77046] - HeLa cell lysate containing 10, 2.5, or 1 ng of full length recombinant eotaxin with eotaxin antibody at 1 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: CCL11/Eotaxin Antibody - BSA Free [NBP1-77046] - Immunocytochemistry of CCL11/Eotaxin in 293 cells with CCL11/Eotaxin antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp1-77046_rabbit-polyclonal-ccl11-eotaxin-antibody-2711202419183822.jpg)
![Immunocytochemistry/ Immunofluorescence: CCL11/Eotaxin Antibody - BSA Free [NBP1-77046] - Immunofluorescence of CCL11/Eotaxin in 293 cells with CCL11/Eotaxin antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-77046_rabbit-polyclonal-ccl11-eotaxin-antibody-271120242092035.jpg)
![Immunohistochemistry-Paraffin: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - CXCR2positive breast cancer cells in the human brain. CXCR2-red fluorochrome, nucleus-DAPI. Antibody used at dilution of 1:100. This image was submitted via customer Review.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Immunohistochemistry-Paraffin-NBP1-43338-img0005.jpg "Immunohistochemistry-Paraffin: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - CXCR2positive breast cancer cells in the human brain. CXCR2-red fluorochrome, nucleus-DAPI. Antibody used at dilution of 1:100. This image was submitted via customer Review.")
![Flow Cytometry: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - Analysis using the PE conjugate of NBP1-43338. Staining of normal human peripheral blood cells with Anti-Human CD4 APC (left) or Anti-Human CD56 (NCAM) APC (right) and Anti-Human CD182 (CXCR2) PE. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Flow-Cytometry-NBP1-43338-img0004.jpg)
![Flow Cytometry: CXCR2/IL-8 RB Antibody (5E8-C7-F10) [NBP1-43338] - Staining of normal human peripheral blood cells with 0.25 ug of Mouse IgG1 kappa Isotype Control Purified (left) or 0.25 ug of Anti-Human CD182 (CXCR2) Purified (right) followed by F(ab')2 Anti-Mouse IgG PE . Cells in the large scatter population were used for analysis.](http://images.novusbio.com/fullsize/CXCR2-IL-8-RB-Antibody-5E8-C7-F10-Flow-Cytometry-NBP1-43338-img0002.jpg)
![Western Blot: CCR1 Antibody (8E10G6) [NBP2-61697] - Analysis using CD191 mAb against human CD191 (AA: extra mix) recombinant protein. (Expected MW is 37 kDa)](http://images.novusbio.com/fullsize/CCR1-Antibody-8E10G6-Western-Blot-NBP2-61697-img0003.jpg "Western Blot: CCR1 Antibody (8E10G6) [NBP2-61697] - Analysis using CD191 mAb against human CD191 (AA: extra mix) recombinant protein. (Expected MW is 37 kDa)")
![Flow Cytometry: CCR1 Antibody (8E10G6) [NBP2-61697] - Analysis of Ramos cells using CD191 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CCR1-Antibody-8E10G6-Flow-Cytometry-NBP2-61697-img0002.jpg)
![Western Blot: CCR1 Antibody (8E10G6) [NBP2-61697] - Analysis using CD191 mAb against HEK293 (1) and CD191 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CCR1-Antibody-8E10G6-Western-Blot-NBP2-61697-img0004.jpg)
![ELISA: CCR1 Antibody (8E10G6) [NBP2-61697] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CCR1-Antibody-8E10G6-ELISA-NBP2-61697-img0001.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0003.jpg "Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)")
![Flow Cytometry: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis of Ramos cells using CD16 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Flow-Cytometry-NBP2-61693-img0002.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against HEK293 (1) and CD16 (AA: extra 17-208)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0004.jpg)
![ELISA: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-ELISA-NBP2-61693-img0001.jpg)